Researchers Identified New COL1A1 Genetic Variant
A study of seven individuals has linked a specific COL1A1 missense mutation to distinct connective tissue symptoms.
Updated on Oct. 12, 2026 in Life Sciences
Scientists have identified a recurrent COL1A1 E678K genetic variant in seven individuals across three unrelated families. The study suggests that current diagnostic terminology for COL1A1-related Ehlers-Danlos syndrome may need expansion to include this phenotype.
Why it matters
The findings were published because the specific symptoms observed in these individuals did not align with previously categorized connective tissue disorders. This identification helps bridge gaps in understanding genotype-phenotype correlations for patients with similar markers.
The identified mutation is a heterozygous exon 31 missense variant labeled c.2032G>A, which results in the p.Glu678Lys amino acid substitution. This variant affects the COL1A1 gene, which encodes procollagen alpha-1 chains of type I collagen.
The details
Researchers performed a detailed clinical and molecular analysis to evaluate the physical markers of the variant, which include joint hypermobility and soft, doughy skin. The subjects also presented with variable degrees of congenital hip dysplasia or dislocation.
Timeline
October 12, 2026: The study was published.
The Big Picture
This discovery updates the existing Ehlers-Danlos syndrome classification criteria by providing a new genetic marker for diagnosis. The finding challenges previous diagnostic limitations and encourages a broader framework for categorizing rare connective tissue variants.
The identification of this genetic variant allows for more precise diagnostic testing for individuals presenting with unexplained joint hypermobility or hip dysplasia. It may eventually lead to more personalized clinical management strategies for patients carrying the p.Glu678Lys mutation.
The takeaway
Understanding specific genetic variants helps clinicians provide accurate diagnoses for patients with connective tissue issues. Families experiencing unexplained joint or skin symptoms should consult with a genetic counselor to discuss emerging testing options.
Further reading
For more information on similar genetic research, explore the latest findings in Life Sciences.
Source note: This article includes information reported by Journal of Medical Genetics.
